Catherine Branger
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.2%
- Escherichia coli research studies
- Enterobacteriaceae and Cronobacter Research
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 33
-
- Escherichia coli research studies 10
- Vibrio bacteria research studies 8
- Co-authors
- Érick DenamurGuillaume ArletOlivier ClermontN Lambert-ZechovskyBertrand PicardSophie VimontAnnie Buu-HoïJ. F. Acar
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Journal of Medical Microbiology (5 papers)Journal of Antimicrobial Chemotherapy (5 papers)Journal of Clinical Microbiology (5 papers)Journal of Hospital Infection (4 papers)
- Partner nations
- FranceUnited KingdomSpain
In The Last Decade
Catherine Branger
67 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 119
- Molecular Medicine 1.6k
- Endocrinology 1.2k
- Applied Microbiology and Biotechnology 122
- Clinical Biochemistry 307
- Critical Care and Intensive Care Medicine 232
Countries citing papers authored by Catherine Branger
This map shows the geographic impact of Catherine Branger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Branger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Branger more than expected).
Fields of papers citing papers by Catherine Branger
This network shows the impact of papers produced by Catherine Branger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Branger. The network helps show where Catherine Branger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Catherine Branger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 29 | |
| 2 | 2017 | 36 | |
| 3 | 2015 | 57 | |
| 4 | 2015 | 40 | |
| 5 | 2015 | 11 | |
| 6 | 2014 | 33 | |
| 7 | 2013 | 33 | |
| 8 | 2013 | 8 | |
| 9 | 2012 | 28 | |
| 10 | 2010 | 83 | |
| 11 | 2008 | 5 | |
| 12 | 2007 | 17 | |
| 13 | 2006 | 5 | |
| 14 | 2006 | 7 | |
| 15 | 1997 | 64 | |
| 16 | 1996 | 54 | |
| 17 | 1989 | 5 | |
| 18 | 1988 | 83 | |
| 19 | 1987 | 27 | |
| 20 | Vancomycin-Resistant Streptococci or sp. | 1985 | 5 |
About Catherine Branger
Catherine Branger is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Clinical Biochemistry and Critical Care and Intensive Care Medicine, having authored 69 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial Identification and Susceptibility Testing (12 papers), Escherichia coli research studies (10 papers), Vibrio bacteria research studies (8 papers), Nosocomial Infections in ICU (8 papers), Bacterial Genetics and Biotechnology (8 papers) and Streptococcal Infections and Treatments (8 papers). The work is most often cited by research in Molecular Medicine (1.6k citations), Endocrinology (1.2k citations), Applied Microbiology and Biotechnology (122 citations), Clinical Biochemistry (307 citations) and Critical Care and Intensive Care Medicine (232 citations). Catherine Branger has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Érick Denamur, Guillaume Arlet, Olivier Clermont, N Lambert-Zechovsky, Bertrand Picard, Sophie Vimont, Annie Buu-Hoï, J. F. Acar, F. Bert and Christiane Forestier. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Medical Microbiology, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology and Journal of Hospital Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.